Antibiotic therapy for ventilator-associated pneumonia: De-escalation in the real world

Critical Care Medicine

Volumn 35, Issue 2, 2007, Pages 632-633

  Depuydt, Pieter ^a   Blot, Stijn ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Antibiotics; Antimicrobial therapy; Nosocomial infection

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC;

ANTIBIOTIC THERAPY; BACTERIAL INFECTION; DRUG CHOICE; EDITORIAL; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MORBIDITY; MORTALITY; PATHOGENESIS; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; STAPHYLOCOCCUS AUREUS; SURVIVAL; VENTILATOR ASSOCIATED PNEUMONIA;

ANTI-BACTERIAL AGENTS; HUMANS; PNEUMONIA, VENTILATOR-ASSOCIATED;

EID: 33846434090     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000254049.23884.D5     Document Type: Editorial

References (15)

1. Kollef MH: What is ventilator-associated pneumonia and why is it important? Respir Care 2005; 50:714-721
2. Myny D, Depuydt P, Colardyn F, et al: Ventilator-associated pneumonia in a tertiary care ICU: Analysis of risk factors for acquisition and mortality. Acta Clin Belg 2005; 60: 114-121
3. Luna CM, Vujacich P, Niederman MS, et al: Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997; 111:676-685
4. Iregui M, Ward S, Sherman G, et al: Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilatorassociated pneumonia. Chest 2002; 122: 262-268
5. Colardyn F: Appropriate and timely empirical antimicrobial treatment of ICU infections-A role for carbapenems. Acta Clin Belg 2005; 60:51-62
6. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416
7. Depuydt P, Benoit D, Vogelaers D, et al: Outcome in bacteremia associated with nosocomial pneumonia and the impact of pathogen prediction by tracheal surveillance cultures. Intensive Care Med 2006; 32:1773-1781
8. Depuydt PO, Blot SI, Benoit DD, et al: Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit. Crit Care Med 2006; 34:653-659
9. Michel F, Franceschini B, Berger P, et al: Early antibiotic treatment for BAL-confirmed ventilator-associated pneumonia: A role for routine endotracheal aspirate cultures. Chest 2005; 127:589-597
10. Rello J, Vidaur L, Sandiumenge A, et al: De-escalation therapy in ventilator-associated pneumonia. Crit Care Med 2004; 32:2183-2190
11. Singh N, Rogers P, Atwood CW, et al: Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000; 162:505-511
12. Chastre J, Wolff M, Fagon JY, et al: Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: A randomized trial. JAMA 2003; 290:2588-2598
13. Leone M, Garcin F, Bouvenot J, et al: Ventilator-associated pneumonia: Breaking the vicious circle of antibiotic overuse. Crit Care Med 2007; 35:379-385
14. Rello J, Ollendorf DA, Oster G, et al: Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002; 122:2115-2121
15. Rello J, Sa-Borges M, Correa H, et al: Variations in etiology of ventilator-associated pneumonia across four treatment sites: Implications for antimicrobial prescribing practices. Am J Respir Crit Care Med 1999; 160: 608-613